MAY 05, 2020 9:00 AM PDT

The Pharmacogenomics Behind the Investigational Treatments of COVID-19 and its High-Risk Underlying Conditions

Sponsored by: Admera Health
C.E. Credits: Florida CE P.A.C.E. CE
Speaker

Abstract
DATE:  May 5, 2020
TIME:   9:00am PT, 12:00pm ET
 
As of May 4, 2020, 1,152,372 total COVID-19 cases and 67,456 total deaths have been reported in the United States (U.S.). Fifty-five U.S. jurisdictions have reported cases including the 50 states, the District of Columbia, Puerto Rico, Guam, the Northern Mariana Islands, and the U.S. Virgin Islands. According to the CDC, older adults and people of any age who have severe underlying medical conditions such as diabetes, chronic lung disease, cardiovascular disease, and any disease that causes the patient to be immunocompromised might be at higher risk for contracting and experiencing severe illness from COVID-19. Most patients with significant underlying chronic medical conditions take medications to mitigate their disease. Also, some patients take medicines that can induce immunosuppression and increase their chances of contracting COVID-19. Pharmacogenomics directed medication therapy management before infection with COVID-19 has the potential to reduce the chances of patients with chronic disease contracting COVID-19 and, it increases their chances for survival from COVID-19 should they become infected. COVID-19 is a novel coronavirus that, once contracted, manifests itself through a wide range of symptoms. The symptoms range anywhere between no signs of COVID-19 at all to death from COVID-19 induced pathophysiology. Many medications are currently proposed for treating COVID-19, and many drugs are now being used to treat COVID-19's sequelae, such as acute respiratory distress syndrome, sepsis, and coagulopathy. Pharmacogenomics directed medication management also has the potential to improve the efficacy of and decrease the toxicity of some medications used to treat COVID-19 and its most common sequelae.
 
Learning Objectives:
  • Describe how pharmacogenomics directed medication therapy management before infection with COVID-19 has the potential to reduce the chances for patients with chronic disease contracting COVID-19
  • Describe how pharmacogenomics directed medication management has the potential to improve the efficacy of and decrease the toxicity of some medications used to treat COVID-19 and its sequelae
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

 

 


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUL 15, 2021 9:00 AM PDT
JUL 15, 2021 9:00 AM PDT
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
JUN 22, 2021 10:00 AM PDT
C.E. CREDITS
JUN 22, 2021 10:00 AM PDT
Date: June 22, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Antimicrobial resistance (AMR) has emerged as one of the principal public health problems of the 21st century. It threatens the effectiv...
MAY 18, 2021 8:00 AM PDT
C.E. CREDITS
MAY 18, 2021 8:00 AM PDT
Date: May 18, 2021 Time: 8:00am (PST) The global pandemic has caused an increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provide qu...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
Loading Comments...
Show Resources